Novel Process Platform for the Manufacturing and Purification of Biosimilar rHu Ranibizumab | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Novel Process Platform for the Manufacturing and Purification of Biosimilar rHu Ranibizumab

Implementing Organization

National Chemical Laboratory (NCL)

About

Age-related macular degeneration . Diabetic retinopathy

Related Research

Quick Information

Area of Research

Medical Sciences

Focus Area

Biosimilar rHu Ranibizumab

Status

completed

Output in Numbers

Research Paper

00

Technologies (If Any)

00

PhD Produced

N/A

Startup (If Any)

00

Patents

Filed :00

Grant :00